Malignant Peritoneal Mesothelioma
📧 Sign up to get email alerts when something new happens for Malignant Peritoneal Mesothelioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: CT-95 in Advanced Cancers Associated With Mesothelin Expression [Phase 1]
Phase 1 trial CT-95 for mesothelin-expressing tumors is currently recruiting across multiple indications, including epithelial ovarian cance…
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma [Phase 2]
This clinical trial update describes an ongoing Phase 2 study evaluating additional chemotherapy after surgery for malignant peritoneal meso…
-
CLINICAL_TRIALS research · 2024-08-07Clinical Trial Update: Sintilimab, Bevacizumab, Pemetrexed, and Cisplatin for Unresectable MPeM [Phase 2]
Phase 2 clinical trial evaluating a four-drug combination of sintilimab, bevacizumab, pemetrexed, and cisplatin for unresectable malignant p…
-
CLINICAL_TRIALS research · 2014-01-06Clinical Trial Update: Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer [Phase 2]
A Phase 2 clinical trial update exploring surgery, chemotherapy, and radiation therapy for malignant peritoneal mesothelioma.
-
CLINICAL_TRIALS research · 2011-10-31Clinical Trial Update: Velcade and Eloxatin for Patients With Malignant Pleural or Peritoneal Mesothelioma [Phase 2]
Phase 2 trial evaluating Velcade (bortezomib) and Eloxatin (oxaliplatin) for malignant pleural or peritoneal mesothelioma. The current statu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.